{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:56:15Z","timestamp":1761947775586},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T00:00:00Z","timestamp":1325116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00428-011-1182-y","type":"journal-article","created":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T09:07:33Z","timestamp":1325063253000},"page":"211-221","source":"Crossref","is-referenced-by-count":14,"title":["Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections"],"prefix":"10.1007","volume":"460","author":[{"given":"Carmen","family":"Valbuena","sequence":"first","affiliation":[]},{"given":"Dina","family":"Leit\u00e3o","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,29]]},"reference":[{"key":"1182_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3733\u20133774","edition":"8"},{"key":"1182_CR2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435","journal-title":"Lancet"},{"key":"1182_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112\u2013128","journal-title":"Mol Genet Metab"},{"key":"1182_CR4","first-page":"221","volume":"34","author":"K Scriba","year":"1950","unstructured":"Scriba K (1950) Zur Pathogenese des Angiokeratoma corporis diffusum Fabry mit cardio vasorenalem symptomenkomplex. Verhandlg Deutsch Path GesellschVerhandlg Deutsch Path Gesellsch 34:221\u2013226","journal-title":"Verhandlg Deutsch Path GesellschVerhandlg Deutsch Path Gesellsch"},{"key":"1182_CR5","first-page":"206","volume":"89","author":"EW Henry","year":"1963","unstructured":"Henry EW, Rally CR (1963) The renal lesion in angiokeratoma corporis diffusum (Fabry\u2019s disease). Canad Med Ass J 89:206\u2013213","journal-title":"Canad Med Ass J"},{"key":"1182_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","volume":"13","author":"MC Gubler","year":"1978","unstructured":"Gubler MC, Lenoir G, Grunfeld JP et al (1978) Early renal changes in hemizygous and heterozygous patients with Fabry\u2019s disease. Kidney Int 13:223\u2013235","journal-title":"Kidney Int"},{"key":"1182_CR7","first-page":"247","volume":"103","author":"T Faraggiana","year":"1981","unstructured":"Faraggiana T, Churg J, Grishman E et al (1981) Light- and electron-microscopic histochemistry of Fabry\u2019s disease. Am J Pathol 103:247\u2013262","journal-title":"Am J Pathol"},{"key":"1182_CR8","first-page":"1200","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"SL Finn","year":"2006","unstructured":"Finn SL, Bernstein J (2006) Renal disease caused by familial metabolic and hematologic disease. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall\u2019s pathology of the kidney, 6th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1200\u20131256","edition":"6"},{"key":"1182_CR9","first-page":"488","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"MC Gubler","year":"2006","unstructured":"Gubler MC, Heidet L, Antignac C (2006) Alport\u2019s syndrome, thin basement membrane nephropathy, Nail\u2013Patella syndrome, and type III collagen glomerulopathy. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall\u2019s pathology of the kidney, 6th edn. Lippincott Williams and Wilkins, Philadelphia, pp 488\u2013517","edition":"6"},{"key":"1182_CR10","first-page":"126","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"JL Olson","year":"2006","unstructured":"Olson JL (2006) The nephrotic syndrome and minimal change disease. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall\u2019s pathology of the kidney, 6th edn. Lippincott Williams and Wilkins, Philadelphia, pp 126\u2013155","edition":"6"},{"key":"1182_CR11","first-page":"109","volume":"15","author":"A Sessa","year":"2002","unstructured":"Sessa A, Toson A, Nebuloni M et al (2002) Renal ultrastructural findings in Anderson\u2013Fabry disease. J Nephrol 15:109\u2013112","journal-title":"J Nephrol"},{"key":"1182_CR12","first-page":"536","volume":"101","author":"M Savi","year":"1977","unstructured":"Savi M, Olivetti G, Neri TM et al (1977) Clinical, histopathological, and biochemical findings in Fabry\u2019s disease. A case report and family study. Arch Pathol Lab Med 101:536\u2013539","journal-title":"Arch Pathol Lab Med"},{"key":"1182_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1144","volume":"310","author":"M Kotani","year":"1994","unstructured":"Kotani M, Kawashima I, Ozawa H et al (1994) Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine. Arch Biochem Biophys 310:89\u201396","journal-title":"Arch Biochem Biophys"},{"key":"1182_CR14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0272-6386(95)90061-6","volume":"26","author":"M Fukushima","year":"1995","unstructured":"Fukushima M, Tsuchiyama Y, Nakato T et al (1995) A female heterozygous patient with Fabry\u2019s disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis 26:952\u2013955","journal-title":"Am J Kidney Dis"},{"key":"1182_CR15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","volume":"451","author":"H Askari","year":"2007","unstructured":"Askari H, Kaneski CR, Semino-Mora C et al (2007) Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch 451:823\u2013834","journal-title":"Virchows Arch"},{"key":"1182_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","volume":"453","author":"C Valbuena","year":"2008","unstructured":"Valbuena C, Carvalho E, Bustorff M et al (2008) Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 453:329\u2013338","journal-title":"Virchows Arch"},{"issue":"Suppl 2","key":"1182_CR17","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","volume":"13","author":"J Alroy","year":"2002","unstructured":"Alroy J, Sabnis S, Kopp JB (2002) Renal pathology in Fabry disease. J Am Soc Nephrol 13(Suppl 2):S134\u2013S138","journal-title":"J Am Soc Nephrol"},{"key":"1182_CR18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800634","volume":"19","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295\u20131301","journal-title":"Mod Pathol"},{"key":"1182_CR19","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo AB, Bostad L, Svarstad E et al (2010) Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant 25:2168\u20132177","journal-title":"Nephrol Dial Transplant"},{"key":"1182_CR20","first-page":"310","volume":"16","author":"A Sessa","year":"2003","unstructured":"Sessa A, Meroni M, Battini G et al (2003) Renal involvement in Anderson\u2013Fabry disease. J Nephrol 16:310\u2013313","journal-title":"J Nephrol"},{"key":"1182_CR21","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","volume":"238","author":"CC Sweeley","year":"1963","unstructured":"Sweeley CC, Klionsky B (1963) Fabry\u2019s disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148\u20133150","journal-title":"J Biol Chem"},{"key":"1182_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-008-0651-4","volume":"453","author":"JP Oliveira","year":"2008","unstructured":"Oliveira JP, Valbuena C, Baldaia Moreira A et al (2008) Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson\u2013Fabry disease. Virchows Arch 453:291\u2013300","journal-title":"Virchows Arch"},{"key":"1182_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2133.2005.06732.x","volume":"153","author":"T Kanekura","year":"2005","unstructured":"Kanekura T, Fukushige T, Kanda A et al (2005) Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol 153:544\u2013548","journal-title":"Br J Dermatol"},{"key":"1182_CR24","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1016\/S0021-9258(18)45495-6","volume":"262","author":"A Cohen","year":"1987","unstructured":"Cohen A, Hannigan GE, Williams BR et al (1987) Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem 262:17088\u201317091","journal-title":"J Biol Chem"},{"key":"1182_CR25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00467-002-1025-9","volume":"18","author":"Z Ergonul","year":"2003","unstructured":"Ergonul Z, Clayton F, Fogo AB et al (2003) Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18:246\u2013253","journal-title":"Pediatr Nephrol"},{"key":"1182_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1523-1755.1998.00015.x","volume":"54","author":"AK Hughes","year":"1998","unstructured":"Hughes AK, Stricklett PK, Kohan DE (1998) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54:426\u2013437","journal-title":"Kidney Int"},{"key":"1182_CR27","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1046\/j.1523-1755.2000.00095.x","volume":"57","author":"AK Hughes","year":"2000","unstructured":"Hughes AK, Stricklett PK, Schmid D et al (2000) Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57:2350\u20132359","journal-title":"Kidney Int"},{"key":"1182_CR28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1523-1755.1998.00939.x","volume":"53","author":"T Taguchi","year":"1998","unstructured":"Taguchi T, Uchida H, Kiyokawa N et al (1998) Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53:1681\u20131688","journal-title":"Kidney Int"},{"key":"1182_CR29","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.295.12.1428","volume":"295","author":"BR Migeon","year":"2006","unstructured":"Migeon BR (2006) The role of X inactivation and cellular mosaicism in women\u2019s health and sex-specific diseases. JAMA 295:1428\u20131433","journal-title":"JAMA"},{"key":"1182_CR30","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1073\/pnas.0437825100","volume":"100","author":"M Novelli","year":"2003","unstructured":"Novelli M, Cossu A, Oukrif D et al (2003) X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 100:3311\u20133314","journal-title":"Proc Natl Acad Sci USA"},{"issue":"705","key":"1182_CR31","first-page":"707","volume":"452","author":"M Elleder","year":"2008","unstructured":"Elleder M (2008) Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch 452(705):707\u2013708","journal-title":"Virchows Arch"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-011-1182-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1182-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T21:23:15Z","timestamp":1640208195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-011-1182-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,29]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1007\/s00428-011-1182-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,29]]}}}